Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Stock In Focus
(Total Views: 91)
Posted On: 08/04/2025 7:40:43 AM
Post# of 160
Avatar
Posted By: jmtimz
- NRx Pharmaceuticals (NASDAQ: $NRXP)
CEO Dr. Jonathan Javitt offers an update on the company's late-stage pharmaceutical developments for bipolar depression, PTSD, and other CNS disorders, while continuing to advance FDA engagement for its proprietary pipeline.
https://finance.yahoo.com/news/street-show-68...00890.html

(0)
(0)








  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site